Indonesia's COVID-19 Vaccination and Economic Resilience Strategy slide image

Indonesia's COVID-19 Vaccination and Economic Resilience Strategy

Republic of Indonesia Samurai Bond JPY 81.0bn Summary of Terms & Conditions Issuer Expected. Bond Rating Format Pricing Date Settlement Date Deal Size Series Tenor Coupon Tranche Size Re-offer Spread over TONA Yen Mid Swap Joint Lead Arrangers 3yr Life Ins. 10% Others International 16% 5% Shinkire, etc. 5% Regional 20% Cerbal 63% Regional BK 11% Pub. Funds (central) 3% Republic of Indonesia Baa2 Moody's BBB S&P / BBB Fitch Samurai June 2, 2022 June 9, 2022 JPY 81.0bn RIJPY0625 RIJPY0627 3-year 0.96% 5-year 1.13% JPY 68.2bn JPY 5.1bn RIJPY0629 7-year 1.27% JPY 1.7bn YMS+90 YMS+100 YMS+105 5yr Prop. Ins RIJPY0632 10-year 1.45% JPY 6.0bn YMS+110 Daiwa/Mizuho/Nomura/Morgan Stanley Investor Breakdown by Amount 7yr International 12% Transaction Highlight • • The largest Samurai bond transaction issued in 2022 so far. This deal represents Rol's eighth consecutive year accessing the Samurai market with benchmark sized transaction since 2015 With the global market volatility being high on the back of tightening monetary policies and heighted geopolitical risk, Rol took the strategy to swiftly access to the market by shortening the marketing period Even with the shortened 2-day official marketing period compared to previous issuance, Japanese investors were ready to invest in Rol Samurai and giving order from early stage of the marketing. Orderbook grew solidly during the marketing; the final order book exceeding the issuance size Others 174 10yr Total Life Is 9% Prop. Ins. 0.2% International 17% City BVK 12% City AM 22% FUK 157 International 43% Central 21% Shirkins, etc. Regional 33% AM Central Cooperative 15% 20% 素 Source: Ministry of Finance Others Regional B8% Others 88% Regional 17% Central NEW Others 9% Regional Shinkins, etc. 22% Central 61% 4% Regional AMM 25% BIK AM 9% 83% Pub. Funds (central) 3% Central Cooperative 12% 104
View entire presentation